Relationship Between Cognitive Impairments and Serum Orexin Levels in Epilepsy Patients

Creative Commons License

Yücel Z., ULUDAĞ İ. F., ŞENER U., SARITEKE A., Baysoy A.

Archives of Epilepsy, cilt.30, sa.3, ss.72-77, 2024 (ESCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 3
  • Basım Tarihi: 2024
  • Doi Numarası: 10.4274/archepilepsy.2024.23097
  • Dergi Adı: Archives of Epilepsy
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.72-77
  • Anahtar Kelimeler: Cognitive, epilepsy, Orexin A
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objective: Recent studies on neurodegenerative diseases have indicated that Orexin A plays a role in cognitive impairment. Furthermore, animal studies have demonstrated that Orexin A enhances synaptic plasticity in the hippocampus. The present study aimed to investigate the potential effect of orexin A on cognitive decline in patients with epilepsy. Methods: This study included patients with epilepsy (patient group), including those with idiopathic generalized epilepsy (IGE subgroup) (n=24) and mesial temporal lobe epilepsy (mTLE subgroup) (n=17), and healthy controls (control group) (n=27), all aged 18-65 years. The Wechsler Memory Scale (WMS) visual memory subtest and Oktem Verbal Memory Processes Test (OVMPT) (15-word Turkish verbal learning memory test) were administered to all participants. Serum Orexin A levels were measured using enzyme-linked immunosorbent assay. Results: The mean Orexin A level in the control group was 25.84±14.65 pg mL-1, versus 24.57±12.50 pg mL-1 in the IGE group and 23.01±12.86 pg mL-1 in the mTLE group. There were no significant differences in the Orexin A level between any of the groups/subgroups. Moreover, no significant correlation was observed between the Orexin A level, WMS visual memory subtest, and OVMPT scores. Conclusion: Our findings showed no association between the Orexin A level and cognitive impairment in patients with epilepsy. Further studies are needed to clarify the complex role of Orexin A in cognitive function.